Cynata Therapeutics Ltd V.CYP

Primary Symbol: CYYNF

Healthcare Biotechnology

Cynata Therapeutics Limited is an Australia-based clinical-stage stem cell and regenerative medicine company. The Company is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells and a precursor cell, mesenchymoangioblast (MCA) to manufacture cell therapy products, including mesenchymal stem cells, on a commercial scale. Its lead product candidate, CYP-001, is under Phase I trial and developed for the treatment of steroid-resistant acute graft-versus-host disease (GvHD). Clinical trials of Cymerus products in osteoarthritis, which is under Phase III trial, and diabetic foot ulcers (DFU) are ongoing. In addition, the Company has demonstrated the utility of its Cymerus technology in preclinical models of various diseases, including critical limb ischaemia, idiopathic pulmonary fibrosis, asthma, heart attack, sepsis, acute respiratory distress syndrome and other.

OTCPK:CYYNF - Post by User

Cynata Therapeutics Ltd

Bullboard Posts

Post by GarryJan1on Oct 11, 2018 9:24pm

115 Views

Post# 28785571

The PP is not a big deal.

Sure it would have been nice to have seen it being higher. I took advantage of the sell off today with a buy of 20000 at 21. I am looking for a return on that well into dollars. I have a few more $$ if gifts keep coming.

I believe some of the selling was to excersize warrants. Why not still close to double what the warrant price is.

Please let it be a good broker that picks up the PP. One that knows the real value of the 9 million tons of lithium at surface just waiting to be processed.

Bullboard Posts

Investing in Canada's lumber market